TWO SIGMA INVESTMENTS, LP - FREELINE THERAPEUTICS HLDGS ownership

FREELINE THERAPEUTICS HLDGS's ticker is FRLN and the CUSIP is 35655L107. A total of 21 filers reported holding FREELINE THERAPEUTICS HLDGS in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of FREELINE THERAPEUTICS HLDGS
ValueSharesWeighting
Q1 2023$19,569
-5.5%
43,005
-1.4%
0.00%
Q4 2022$20,717
-42.5%
43,605
-14.3%
0.00%
Q3 2022$36,000
-39.0%
50,905
-25.2%
0.00%
Q2 2022$59,000
-60.4%
68,041
-48.8%
0.00%
Q1 2022$149,000
+84.0%
132,822
+223.4%
0.00%
Q4 2021$81,000
-72.4%
41,073
-52.2%
0.00%
-100.0%
Q3 2021$293,00085,9590.00%
Other shareholders
FREELINE THERAPEUTICS HLDGS shareholders Q3 2021
NameSharesValueWeighting ↓
CHI Advisors LLC 1,361,064$24,853,0007.00%
Novo Holdings A/S 2,361,229$43,116,0001.85%
Ally Bridge Group (NY) LLC 425,000$7,761,0001.33%
TFG Asset Management GP Ltd 750,000$13,695,0000.92%
SECTORAL ASSET MANAGEMENT INC 657,494$12,006,0000.85%
FRAZIER MANAGEMENT LLC 550,000$10,043,0000.77%
Eventide Asset Management 2,485,656$44,266,0000.68%
Ovata Capital Management Ltd 14,981$274,0000.09%
AXA S.A. 551,476$10,070,0000.03%
Woodline Partners LP 25,932$474,0000.01%
View complete list of FREELINE THERAPEUTICS HLDGS shareholders